News
Firing on all cylinders - Q4 initial take
Rikard Engberg
2026-02-26
08:11 CET
Mentice delivered a strong finish to the year, with all reported figures exceeding our estimates. The solid sales and order intake were primarily driven by a broader customer base within the Medical Device Industry (MDI), in our view. Given the strength of the report and a robust order book at year-end, we expect strong share price performance during the day.
Overall conclusion. Revenue amounted to SEK90.8m, corresponding to organic growth of 17.6% and 4.4% above our estimate for the quarter. EBITDA was SEK23.0m, implying a margin of 24.8% and coming in 21% above our forecast. We believe the outperformance was driven by higher-than-expected sales, a strong gross margin, and continued cost discipline. Order intake reached SEK126.8m, corresponding to organic growth of 25.3% and 7.6% above our estimate. The primary driver, in our opinion, was the MDI segment, which grew 15.4% organically Y/Y. The order book at the end of the quarter amounted to SEK130m, representing 3.8% growth and 1.8% above our estimate. Of this, SEK87m is expected by Mentice to be delivered during 2026, providing good near-term revenue visibility.
Estimate revisions. Given the stronger-than-expected order book and continued cost control, we expect upward revisions to our estimates. Approximately 27% of our 2026e revenue forecast is already secured in the order book.
Share price reaction. Given the strength of the reported figures and improved visibility, we expect the stock to outperform the broader market today.